CD4 c.239_240inv ;(p.A80E)

Variant ID: 12-6923332-CT-AG

NM_000616.4(CD4):c.239_240inv;(p.A80E)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients.

Clinical Epigenetics
Manoochehri, Mehdi M; Hielscher, Thomas T; Borhani, Nasim N; Gerhäuser, Clarissa C; Fletcher, Olivia O; Swerdlow, Anthony J AJ; Ko, Yon-Dschun YD; Brauch, Hiltrud H; Brüning, Thomas T; Hamann, Ute U
Publication Date: 2021-11-17

Variant appearance in text: CD4: A80E
PubMed Link: 34789319
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeting self and neo-epitopes with a modular self-adjuvanting cancer vaccine.

Jci Insight
Belnoue, Elodie E; Mayol, Jean-François JF; Carboni, Susanna S; Di Berardino Besson, Wilma W; Dupuychaffray, Eloise E; Nelde, Annika A; Stevanovic, Stefan S; Santiago-Raber, Marie-Laure ML; Walker, Paul R PR; Derouazi, Madiha M
Publication Date: 2019-04-23

Variant appearance in text: CD4: A80E
PubMed Link: 31013258
Variant Present in the following documents:
  • Main text
View BVdb publication page